{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:50:44Z","timestamp":1782384644261,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.dmd.2026.100324","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:21:50Z","timestamp":1778628110000},"page":"100324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An in vitro approach to predict idiosyncratic drug-induced agranulocytosis using myeloperoxidase-derived reactive metabolites"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-7481","authenticated-orcid":false,"given":"Tomoyuki","family":"Kawachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5988","authenticated-orcid":false,"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.dmd.2026.100324_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.dmd.2026.100324_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/17425255.2015.985649","article-title":"Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis","volume":"11","author":"Johnston","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"12","key":"10.1016\/j.dmd.2026.100324_bib3","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1124\/dmd.109.028860","article-title":"Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins","volume":"37","author":"Usui","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmd.2026.100324_bib4","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1021\/tx050095o","article-title":"A comparison of the covalent binding of clozapine, procainamide, and vesnarinone to human neutrophils in vitro and rat tissues in vitro and in vivo","volume":"18","author":"Gardner","year":"2005","journal-title":"Chem Res Toxicol"},{"issue":"5","key":"10.1016\/j.dmd.2026.100324_bib5","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1021\/tx2005635","article-title":"Potential role of a quetiapine metabolite in quetiapine-induced neutropenia and agranulocytosis","volume":"25","author":"Li","year":"2012","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"10.1016\/j.dmd.2026.100324_bib6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2133\/dmpk.24.245","article-title":"A trapping method for semi-quantitative assessment of reactive metabolite formation using [35S]cysteine and [14C]cyanide","volume":"24","author":"Inoue","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"issue":"5","key":"10.1016\/j.dmd.2026.100324_bib7","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.drudis.2016.11.018","article-title":"Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug design","volume":"22","author":"Brink","year":"2017","journal-title":"Drug Discov Today"},{"issue":"4","key":"10.1016\/j.dmd.2026.100324_bib8","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13312-011-0055-4","article-title":"Receiver operating characteristic (ROC) curve for medical researchers","volume":"48","author":"Kumar","year":"2011","journal-title":"Indian Pediatr"},{"issue":"suppl 2","key":"10.1016\/j.dmd.2026.100324_bib9","first-page":"299S","article-title":"Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone)","volume":"10","author":"Volz","year":"1980","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"10.1016\/j.dmd.2026.100324_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1021\/tx980148k","article-title":"Metabolism-dependent neutrophil cytotoxicity of amodiaquine: A comparison with pyronaridine and related antimalarial drugs","volume":"11","author":"Naisbitt","year":"1998","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.dmd.2026.100324_bib12","author":"Annex"},{"issue":"3","key":"10.1016\/j.dmd.2026.100324_bib13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1124\/pharmrev.120.000090","article-title":"The emerging role of the innate immune response in idiosyncratic drug reactions","volume":"73","author":"Sernoskie","year":"2021","journal-title":"Pharmacol Rev"},{"issue":"6","key":"10.1016\/j.dmd.2026.100324_bib14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/dmd.112.045021","article-title":"Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement","volume":"40","author":"Wolford","year":"2012","journal-title":"Drug Metab Dispos"},{"issue":"7903","key":"10.1016\/j.dmd.2026.100324_bib16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0140-6736(75)91305-7","article-title":"Neutropenia associated with metiamide","volume":"1","author":"Forrest","year":"1975","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.dmd.2026.100324_bib17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s00044-015-1484-8","article-title":"Structure and toxicity of clozapine and olanzapine on agranulocytosis","volume":"25","author":"Borges","year":"2016","journal-title":"Med Chem Res"},{"issue":"1","key":"10.1016\/j.dmd.2026.100324_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/toxsci\/kfab154","article-title":"Clozapine induces an acute proinflammatory response that is attenuated by inhibition of inflammasome signaling: implications for idiosyncratic drug-induced agranulocytosis","volume":"186","author":"Sernoskie","year":"2022","journal-title":"Toxicol Sci"},{"issue":"2","key":"10.1016\/j.dmd.2026.100324_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0090-9556(25)06526-2","article-title":"Oxidation of 5-aminosalicylic acid by hypochlorous acid to a reactive iminoquinone: possible role in the treatment of inflammatory bowel diseases","volume":"23","author":"Liu","year":"1995","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmd.2026.100324_bib20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1021\/tx00044a007","article-title":"Oxidation of aminopyrine by hypochlorite to a reactive dication: possible implications for aminopyrine-induced agranulocytosis","volume":"8","author":"Uetrecht","year":"1995","journal-title":"Chem Res Toxicol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955626000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T10:23:48Z","timestamp":1782383028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955626000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0090955626000930"],"URL":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100324","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in vitro approach to predict idiosyncratic drug-induced agranulocytosis using myeloperoxidase-derived reactive metabolites","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmd.2026.100324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100324"}}